These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17517919)

  • 41. Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2.
    Dhalluin C; Ross A; Huber W; Gerber P; Brugger D; Gsell B; Senn H
    Bioconjug Chem; 2005; 16(3):518-27. PubMed ID: 15898717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human interferons alpha, beta and omega.
    Bekisz J; Schmeisser H; Hernandez J; Goldman ND; Zoon KC
    Growth Factors; 2004 Dec; 22(4):243-51. PubMed ID: 15621727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-α receptor 1 antibody.
    Peng L; Oganesyan V; Wu H; Dall'Acqua WF; Damschroder MM
    MAbs; 2015; 7(2):428-39. PubMed ID: 25606664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct signature type I interferon responses are determined by the infecting virus and the target cell.
    Baig E; Fish EN
    Antivir Ther; 2008; 13(3):409-22. PubMed ID: 18572754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.
    Chill JH; Quadt SR; Anglister J
    Biochemistry; 2004 Aug; 43(31):10127-37. PubMed ID: 15287740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The carboxyterminal domains of human IFN-alpha2 and IFN-alpha8 are antigenically homologous.
    Vancová I; Kontseková E; Mucha V; Kontsek P
    J Interferon Cytokine Res; 2000 May; 20(5):455-61. PubMed ID: 10841073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural integrity with functional plasticity: what type I IFN receptor polymorphisms reveal.
    de Weerd NA; Vivian JP; Lim SS; Huang SU; Hertzog PJ
    J Leukoc Biol; 2020 Sep; 108(3):909-924. PubMed ID: 33448473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
    Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
    J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential receptor subunit affinities of type I interferons govern differential signal activation.
    Jaks E; Gavutis M; Uzé G; Martal J; Piehler J
    J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The design and recombinant protein expression of a consensus porcine interferon: CoPoIFN-α.
    Huang L; Cao RB; Wang N; Liu K; Wei JC; Isahg H; Song LJ; Zuo WY; Zhou B; Wang WW; Mao X; Chen PY
    Cytokine; 2012 Jan; 57(1):37-45. PubMed ID: 22088600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes.
    Li Y; Ashuo A; Hao M; Li Y; Ye J; Liu J; Hua T; Fang Z; Li J; Yuan Z; Chen J
    Emerg Microbes Infect; 2024 Dec; 13(1):2287681. PubMed ID: 37994664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the dynamic nature of the transition state for protein-protein association as determined by double-mutant cycle analysis and simulation.
    Harel M; Cohen M; Schreiber G
    J Mol Biol; 2007 Aug; 371(1):180-96. PubMed ID: 17561113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-glycosylation of murine IFN-beta in a putative receptor-binding region.
    Sommereyns C; Michiels T
    J Interferon Cytokine Res; 2006 Jun; 26(6):406-13. PubMed ID: 16734561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in activity between alpha and beta type I interferons explored by mutational analysis.
    Runkel L; Pfeffer L; Lewerenz M; Monneron D; Yang CH; Murti A; Pellegrini S; Goelz S; Uzé G; Mogensen K
    J Biol Chem; 1998 Apr; 273(14):8003-8. PubMed ID: 9525899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The receptor of the type I interferon family.
    Uzé G; Schreiber G; Piehler J; Pellegrini S
    Curr Top Microbiol Immunol; 2007; 316():71-95. PubMed ID: 17969444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural basis of the broadly neutralizing anti-interferon-α antibody rontalizumab.
    Maurer B; Bosanac I; Shia S; Kwong M; Corpuz R; Vandlen R; Schmidt K; Eigenbrot C
    Protein Sci; 2015 Sep; 24(9):1440-50. PubMed ID: 26099203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R.
    Harris BD; Schreiter J; Chevrier M; Jordan JL; Walter MR
    J Biol Chem; 2018 Oct; 293(41):16057-16068. PubMed ID: 30171073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type I interferon receptors in goose: molecular cloning, structural identification, evolutionary analysis and age-related tissue expression profile.
    Zhou H; Chen S; Qi Y; Zhou Q; Wang M; Jia R; Zhu D; Liu M; Sun K; Liu F; Chen X; Cheng A
    Gene; 2015 Apr; 561(1):35-44. PubMed ID: 25617523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity.
    Runkel L; deDios C; Karpusas M; Betzenhauser M; Muldowney C; Zafari M; Benjamin CD; Miller S; Hochman PS; Whitty A
    Biochemistry; 2000 Mar; 39(10):2538-51. PubMed ID: 10704203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling.
    de Weerd NA; Matthews AY; Pattie PR; Bourke NM; Lim SS; Vivian JP; Rossjohn J; Hertzog PJ
    J Biol Chem; 2017 May; 292(18):7554-7565. PubMed ID: 28289093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.